PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 77 filers reported holding PROQR THRAPEUTICS N V in Q4 2021. The put-call ratio across all filers is 2.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $85,492 | +6.7% | 51,501 | +47.1% | 0.00% | – |
| Q1 2024 | $80,149 | +154.6% | 35,001 | +120.1% | 0.00% | – |
| Q4 2023 | $31,484 | +261.4% | 15,901 | +137.3% | 0.00% | – |
| Q3 2023 | $8,711 | -45.8% | 6,701 | -32.5% | 0.00% | – |
| Q2 2023 | $16,082 | +1394.6% | 9,927 | +1865.7% | 0.00% | – |
| Q1 2023 | $1,076 | -86.8% | 505 | -77.1% | 0.00% | – |
| Q4 2022 | $8,158 | -76.0% | 2,205 | +4693.5% | 0.00% | – |
| Q3 2022 | $34,000 | -98.5% | 46 | -98.5% | 0.00% | – |
| Q2 2022 | $2,344,000 | -87.4% | 3,014 | +29.6% | 0.00% | – |
| Q4 2021 | $18,631,000 | +787.2% | 2,326 | +365.2% | 0.00% | – |
| Q4 2020 | $2,100,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,922,570 | $19,053,000 | 7.16% |
| DAFNA Capital Management LLC | 1,114,000 | $11,040,000 | 3.79% |
| RTW INVESTMENTS, LP | 4,779,135 | $47,361,000 | 1.79% |
| Kerrisdale Advisers, LLC | 448,880 | $4,448,000 | 1.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 805,000 | $7,978,000 | 0.66% |
| Artal Group S.A. | 1,300,000 | $12,883,000 | 0.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,571,319 | $45,302,000 | 0.11% |
| ALTRINSIC GLOBAL ADVISORS LLC | 221,360 | $2,194,000 | 0.09% |
| COWEN AND COMPANY, LLC | 103,727 | $1,028,000 | 0.09% |
| FRANKLIN STREET ADVISORS INC /NC | 60,000 | $595,000 | 0.07% |